1
|
Zhou Y, Chen J, Li S, Chen A, Dai C, Liu M, Lu D, Chen Z, Wang X, Qian J, Ge J. Prognostic implication of lipidomics in patients with coronary total occlusion undergoing PCI. Eur J Clin Invest 2022; 52:e13826. [PMID: 35723949 PMCID: PMC9786902 DOI: 10.1111/eci.13826] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/11/2022] [Accepted: 06/17/2022] [Indexed: 12/30/2022]
Abstract
BACKGROUND Predictors of prognosis in patients with coronary chronic total occlusion (CTO) undergoing elective percutaneous coronary intervention (PCI) have remained lacking. Lipidomic profiling enables researchers to associate lipid species with disease progression and may improve the prediction of cardiovascular events. METHODS In the present study, 781 lipids were measured by targeted lipidomic profiling in 350 individuals (50 healthy controls, 50 patients with coronary artery disease and 250 patients with CTO). L1-regularized logistic regression was used to identify lipid species associated with adverse cardiovascular events and create predicting models, which were verified by 10-fold cross-validation (200 repeats). Comparisons were made between a traditional model constructed with clinical characteristics alone and a combined model built with both lipidomic data and traditional factors. RESULTS Twenty-four lipid species were dysregulated exclusively in patients with CTO, most of which belonged to sphingomyelin (SM) and triacylglycerol (TAG). Compared with traditional risk factors, new model combining lipids and traditional factors had significantly improved performance in predicting adverse cardiovascular events in CTO patients after PCI (area under the curve, 0.870 vs. 0.726, p < .05; Akaike information criterion, 129 versus 156; net reclassification improvement, 0.312, p < .001; integrated discrimination improvement, 0.244, p < .001). Nomogram was built based on the incorporated model and proved efficient by Kaplan-Meier method. CONCLUSIONS Lipidomic profiling revealed lipid species which may participate in the formation of CTO and could contribute to the risk stratification in CTO patients undergoing PCI.
Collapse
Affiliation(s)
- You Zhou
- Department of CardiologyShanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University; National Clinical Research Center for Interventional Medicine; Shanghai Clinical Research Center for Interventional MedicineShanghaiPeople's Republic of China
| | - Jinxiang Chen
- Department of CardiologyShanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University; National Clinical Research Center for Interventional Medicine; Shanghai Clinical Research Center for Interventional MedicineShanghaiPeople's Republic of China
| | - Su Li
- Department of CardiologyShanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University; National Clinical Research Center for Interventional Medicine; Shanghai Clinical Research Center for Interventional MedicineShanghaiPeople's Republic of China
| | - Ao Chen
- Department of CardiologyShanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University; National Clinical Research Center for Interventional Medicine; Shanghai Clinical Research Center for Interventional MedicineShanghaiPeople's Republic of China
| | - Chunfeng Dai
- Department of CardiologyShanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University; National Clinical Research Center for Interventional Medicine; Shanghai Clinical Research Center for Interventional MedicineShanghaiPeople's Republic of China
| | - Muyin Liu
- Department of CardiologyShanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University; National Clinical Research Center for Interventional Medicine; Shanghai Clinical Research Center for Interventional MedicineShanghaiPeople's Republic of China
| | - Danbo Lu
- Department of CardiologyShanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University; National Clinical Research Center for Interventional Medicine; Shanghai Clinical Research Center for Interventional MedicineShanghaiPeople's Republic of China
| | - Zhangwei Chen
- Department of CardiologyShanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University; National Clinical Research Center for Interventional Medicine; Shanghai Clinical Research Center for Interventional MedicineShanghaiPeople's Republic of China
| | - Xiangdong Wang
- Shanghai Institute of Clinical BioinformaticsFudan University Center of Clinical Bioinformatics; Shanghai Respiratory Research InstituteShanghaiPeople's Republic of China
| | - Juying Qian
- Department of CardiologyShanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University; National Clinical Research Center for Interventional Medicine; Shanghai Clinical Research Center for Interventional MedicineShanghaiPeople's Republic of China
| | - Junbo Ge
- Department of CardiologyShanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University; National Clinical Research Center for Interventional Medicine; Shanghai Clinical Research Center for Interventional MedicineShanghaiPeople's Republic of China
| |
Collapse
|
2
|
Mantovani A, Bonapace S, Lunardi G, Salgarello M, Dugo C, Gori S, Barbieri E, Verlato G, Laaksonen R, Byrne CD, Targher G. Association of Plasma Ceramides With Myocardial Perfusion in Patients With Coronary Artery Disease Undergoing Stress Myocardial Perfusion Scintigraphy. Arterioscler Thromb Vasc Biol 2019; 38:2854-2861. [PMID: 30571175 DOI: 10.1161/atvbaha.118.311927] [Citation(s) in RCA: 25] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Objective- It is known that specific plasma ceramides are associated with stress-induced reversible myocardial perfusion defects in patients with established or suspected coronary artery disease undergoing myocardial perfusion scintigraphy (MPS). However, it is currently uncertain whether plasma ceramides are also associated with reduced poststress myocardial perfusion in these patients. Approach and Results- We measured 6 previously identified high-risk plasma ceramide species (ceramide [d18:1/16:0], ceramide [d18:1/18:0], ceramide [d18:1/20:0], ceramide [d18:1/22:0], ceramide [d18:1/24:0], and ceramide [d18:1/24:1]) in 167 consecutive patients with established or suspected coronary artery disease undergoing stress MPS for clinical indications. Plasma ceramides were measured by a targeted liquid chromatography-tandem mass spectrometry assay both at baseline and after MPS. Multivariable linear regression analysis was undertaken to examine the associations (standardized B coefficients) between plasma ceramides and the percentage of poststress myocardial perfusion after adjustment for multiple cardiovascular risk factors. Seventy-eight patients had stress-induced myocardial ischemia on MPS (mainly located in the anteroapical wall). Of the 6 measured plasma ceramides, higher levels of basal ceramide (d18:1/18:0; B=-0.182; P=0.019), ceramide (d18:1/20:0; B=-0.224; P=0.004), ceramide (d18:1/22:0; B=-0.163; P=0.035), and ceramide (d18:1/24:1; B=-0.20; P=0.010) were associated with lower poststress anteroapical wall perfusion. Notably, these significant associations persisted even after adjustment for conventional cardiovascular risk factors, previous coronary artery disease, electrocardiographic left bundle branch block, left ventricular ejection fraction and type of stress testing. Similar results were observed for poststress plasma ceramides. Conclusions- Higher circulating levels of specific ceramides, both at baseline and after stress, were independently associated with lower poststress anteroapical wall perfusion in patients with suspected or established coronary artery disease referred for clinically indicated MPS.
Collapse
Affiliation(s)
- Alessandro Mantovani
- From the Section of Endocrinology, Diabetes, and Metabolism, Department of Medicine, University and Azienda Ospedaliera Universitaria Integrata of Verona, Italy (A.M., G.T.)
| | - Stefano Bonapace
- Division of Cardiology (S.B., C.D., E.B.), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Sacro Cuore - Don Calabria Hospital, Negrar (VR), Italy
| | - Gianluigi Lunardi
- Division of Medical Oncology (G.L., S.G.), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Sacro Cuore - Don Calabria Hospital, Negrar (VR), Italy
| | - Matteo Salgarello
- Division of Nuclear Medicine (M.S.), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Sacro Cuore - Don Calabria Hospital, Negrar (VR), Italy
| | - Clementina Dugo
- Division of Cardiology (S.B., C.D., E.B.), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Sacro Cuore - Don Calabria Hospital, Negrar (VR), Italy
| | - Stefania Gori
- Division of Medical Oncology (G.L., S.G.), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Sacro Cuore - Don Calabria Hospital, Negrar (VR), Italy
| | - Enrico Barbieri
- Division of Cardiology (S.B., C.D., E.B.), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Sacro Cuore - Don Calabria Hospital, Negrar (VR), Italy
| | - Giuseppe Verlato
- Unit of Epidemiology and Medical Statistics, Department of Medicine and Public Health, University of Verona, Italy (G.V.)
| | - Reijo Laaksonen
- Finnish Cardiovascular Research Center Tampere, University of Tampere, Faculty of Medicine and Life Sciences and Tampere University Hospital, Finland (R.L.).,Zora Biosciences Oy, Espoo, Finland (R.L.)
| | - Christopher D Byrne
- Southampton National Institute for Health Research Biomedical Research Centre, University Hospital Southampton, Southampton General Hospital, United Kingdom (C.D.B.).,Nutrition and Metabolism, University of Southampton, United Kingdom (C.D.B.)
| | - Giovanni Targher
- From the Section of Endocrinology, Diabetes, and Metabolism, Department of Medicine, University and Azienda Ospedaliera Universitaria Integrata of Verona, Italy (A.M., G.T.)
| |
Collapse
|
3
|
Anroedh S, Hilvo M, Akkerhuis KM, Kauhanen D, Koistinen K, Oemrawsingh R, Serruys P, van Geuns RJ, Boersma E, Laaksonen R, Kardys I. Plasma concentrations of molecular lipid species predict long-term clinical outcome in coronary artery disease patients. J Lipid Res 2018; 59:1729-1737. [PMID: 29858423 DOI: 10.1194/jlr.p081281] [Citation(s) in RCA: 100] [Impact Index Per Article: 16.7] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/18/2017] [Revised: 05/10/2018] [Indexed: 12/21/2022] Open
Abstract
We investigated the associations of ten previously identified high risk molecular lipid species and three ceramide ratios with the occurrence of major adverse cardiac events (MACEs) during a median follow-up of 4.7 years in patients with coronary artery disease (CAD). Between 2008 and 2011, 581 patients underwent diagnostic coronary angiography or percutaneous coronary intervention for stable angina pectoris (SAP) or acute coronary syndrome (ACS). Blood was drawn prior to the index procedure and lipid species were determined. The primary endpoint was the occurrence of a MACE, comprising all-cause mortality, nonfatal ACS, or unplanned coronary revascularization. The secondary endpoint comprised all-cause mortality or nonfatal ACS. During a median follow-up of 4.7 [IQR: 4.2-5.6] years, 155 patients (27%) had MACEs. In multivariable analyses, Cer(d18:1/16:0) concentration was associated with MACEs {hazard ratio 2.32; 95% CI [1.09-4.96] per natural logarithm (ln) (pmol/ml) P = 0.030} after adjustment for cardiac risk factors, clinical presentation, statin use at baseline, and admission nonHDL cholesterol level. Furthermore, after multivariable adjustment, concentrations of Cer(d18:1/16:0), Cer(d18:1/20:0), Cer(d18:1/24:1), and their ratios to Cer(d18:1/24:0) were associated with the composite endpoint death or nonfatal ACS. The data together show the circulating ceramide lipids we investigated here are associated with adverse cardiac outcome during long-term follow-up independent of clinical risk factors.
Collapse
Affiliation(s)
- Sharda Anroedh
- Department of Cardiology, Erasmus MC, Rotterdam, The Netherlands; Cardiovascular Research School COEUR, Erasmus MC, Rotterdam, The Netherlands
| | | | - K Martijn Akkerhuis
- Department of Cardiology, Erasmus MC, Rotterdam, The Netherlands; Cardiovascular Research School COEUR, Erasmus MC, Rotterdam, The Netherlands
| | | | | | - Rohit Oemrawsingh
- Department of Cardiology, Erasmus MC, Rotterdam, The Netherlands; Cardiovascular Research School COEUR, Erasmus MC, Rotterdam, The Netherlands
| | - Patrick Serruys
- Faculty of Medicine, National Heart & Lung Institute, Imperial College London, London, United Kingdom
| | - Robert-Jan van Geuns
- Department of Cardiology, Erasmus MC, Rotterdam, The Netherlands; Radboud University Medical Center, Nijmegen, The Netherlands
| | - Eric Boersma
- Department of Cardiology, Erasmus MC, Rotterdam, The Netherlands; Cardiovascular Research School COEUR, Erasmus MC, Rotterdam, The Netherlands
| | - Reijo Laaksonen
- Zora Biosciences Oy, Espoo, Finland; Finnish Cardiovascular Research Center Tampere, University of Tampere, Tampere, Finland and Finnish Clinical Biobank Tampere, University Hospital of Tampere, Tampere Finland; and
| | - Isabella Kardys
- Department of Cardiology, Erasmus MC, Rotterdam, The Netherlands; Cardiovascular Research School COEUR, Erasmus MC, Rotterdam, The Netherlands.
| |
Collapse
|
4
|
Hoefer IE, Steffens S, Ala-Korpela M, Bäck M, Badimon L, Bochaton-Piallat ML, Boulanger CM, Caligiuri G, Dimmeler S, Egido J, Evans PC, Guzik T, Kwak BR, Landmesser U, Mayr M, Monaco C, Pasterkamp G, Tuñón J, Weber C. Novel methodologies for biomarker discovery in atherosclerosis. Eur Heart J 2015; 36:2635-42. [DOI: 10.1093/eurheartj/ehv236] [Citation(s) in RCA: 140] [Impact Index Per Article: 15.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/20/2015] [Accepted: 05/18/2015] [Indexed: 01/21/2023] Open
|
5
|
Dudzik D, Revello R, Barbas C, Bartha JL. LC–MS-Based Metabolomics Identification of Novel Biomarkers of Chorioamnionitis and Its Associated Perinatal Neurological Damage. J Proteome Res 2015; 14:1432-44. [DOI: 10.1021/pr501087x] [Citation(s) in RCA: 19] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
Affiliation(s)
- Danuta Dudzik
- CEMBIO
(Center for Metabolomics and Bioanalysis), Pharmacy Faculty, University San Pablo CEU, 28668 Madrid, Spain
| | - Rocio Revello
- Division
of Maternal and Fetal Medicine, University Hospital La Paz, 28046 Madrid, Spain
| | - Coral Barbas
- CEMBIO
(Center for Metabolomics and Bioanalysis), Pharmacy Faculty, University San Pablo CEU, 28668 Madrid, Spain
| | - Jose L. Bartha
- Division
of Maternal and Fetal Medicine, University Hospital La Paz, 28046 Madrid, Spain
| |
Collapse
|
6
|
Fadini GP. Age-associated cardiovascular risk and metabolomics of mitochondrial dysfunction. Atherosclerosis 2013; 232:257-8. [PMID: 24468135 DOI: 10.1016/j.atherosclerosis.2013.10.038] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/30/2013] [Accepted: 10/31/2013] [Indexed: 01/29/2023]
Affiliation(s)
- Gian Paolo Fadini
- Department of Medicine, University of Padova, Italy; Venetian Institute of Molecular Medicine, Padova, Italy.
| |
Collapse
|